Uses a fourth-generation combination immunoassay to detect HIV-1 p24 antigen and antibodies to HIV-1 and HIV-2.
Used for routine HIV screening, including during pregnancy, or after possible exposure. It may also be ordered when symptoms suggest early or established HIV infection. Reactive screening results require follow-up testing for confirmation.